Molecular Comparative Study of Virulence Factors Produced by Gram-Negative Bacteria Isolated from Several Cancer Cases and NonCancer Patients in Erbil Governorate, Iraq

Authors

DOI:

https://doi.org/10.25156/ptj.v12n2y2022.pp92-99

Keywords:

Gram-negative bacteria, cancerous patients, non-cancerous patients, virulence genes

Abstract

Background and objectives: Gram-negative bacteria are one of the most prevalent complications among immunocompromised cancer sufferers and pose the greatest threat to these patients.

Our study aimed to conduct research on Gram-negative bacteria isolated from various clinical samples among cancerous patients and non-cancerous patients in Erbil city to analyze and compare some virulence genes among them such as tuf, atpD1, atpD2, ms-1, ms-2 and ms-3.

Methods: The current study was carried out in Nanakaly hospital and other public health hospitals in Erbil- Kurdistan region at a period extending from August 2021 to March 2022.  A total of 100 different clinical samples including urine, sputum, wound swab, stool, blood, have been collected from patients with different types of cancer (n=50) and non-cancerous patients (n=50), from both gender (male and female), without limited age group. Gram-negative bacterial isolates identified by microscopical, macroscopical analysis and Vitek II compact system.

Results: The results of amplification of tuf gene among the cancerous patients were (70%), while the results among the non-cancerous patients was (52%). The percentage of atpD1 from cancer patients were (52%), as well as the appearance among non-cancerous patients were (44%) isolates. The results of atpD2 among cancer patients were (52%). However, the average of atpD2 among patients without cancer were (48%). The results of agarose gel electrophoresis of amplicons appeared that (32%) samples possess ms-1 among cancer cases, while there have not any positive results for control patients. Also, the results of ms-2 gene were (28%) from cancer patients, whereas, the prevalence of ms-2 gene marker among patients without cancer was (6%). The distribution of ms-3 gene was (22%) among cancer patients. Otherwise, the prevalence from samples of patients other than cancer were (20%). According to the statistical tests, the results showed no significant association between genes and type of bacteria in cancerous patients as well as in non-cancerous patients.

Conclusions: tuf, atpD1 and atpD2 genes sealed a discriminated gene as a virulence factor encoding genes for identification of gram-negative bacteria. To the public health and especially from patients with cancer there is a main distribution of ms-1, ms-2 and ms-3 genes among gram-negative bacteria.

Downloads

Download data is not yet available.

References

AHMAD, H., MASROOR, T., PARMAR, S. A. 2021. Urinary tract infection by a rare pathogen Cedecea neteri in a pregnant female with Polyhydramnios: rare case report from UAE. BMC Infectious Diseases, 21, 1-6.

AKINOSOGLOU, K., PERPERIS, A., SIAGRIS, D., GOUTOU, P., SPILIOPOULOU, I., GOGOS, C. 2012. Bacteraemia due to Cedecea davisae in a patient with sigmoid colon cancer: a case report and brief review of the literature. Diagnostic Microbiology and Infectious Disease, 74, 303-306.

ASHREEN, S., AHMED, A., HASAN, N., 2019. Isolation and Identification of Gram-Negative Bacteria from Oral Cancer Site Infections and Study of Their Antibiotic Resistance Pattern. Bangladesh Journal of Microbiology, 36, 85-90.

CARICATO, A., MONTINI, L., BELLO, G., MICHETTI, V., MAVIGLIA, R., BOCCI, M. G., MERCURIO, G., 2009. Risk factors and outcome of Acinetobacter baumanii infection in severe trauma patients. Intensive Care Medicine, 35, 1964-1969.

CHAUDHURI, R. 2012. The evolution of the Escherichia coli phylogeny. Infection, Genetics and Evolution, 12, 214-226.

DAGA, A. P., KOGA, V. L., SONCINI, J. G. M., DE MATOS, C. M., PERUGINI, M. R. E., PELISSON, M., KOBAYASHI, R. 2019. Escherichia coli bloodstream infections in patients at a university hospital: virulence factors and clinical characteristics. Frontiers in Cellular and Infection Microbiology, 9, 191.

DRANCOURT, M., BOLLET, C., CARLIOZ, A., MARTELIN, R., GAYRAL, J.-P. & RAOULT, D. 2000. 16S ribosomal DNA sequence analysis of a large collection of environmental and clinical unidentifiable bacterial isolates. Journal of Clinical Microbiology, 38, 3623-3630.

FUKUTA, Y., MUDER, R. R., AGHA, M. E., CLARKE, L. G., WAGENER, M. M., HENSLER, A. M. 2013. Risk factors for acquisition of multidrug-resistant Acinetobacter baumannii among cancer patients. American Journal of Infection Control, 41, 1249-1252.

GARG, V. K., MISHRA, S., GUPTA, N., GARG, R., SACHIDANAND, B., VINOD, K., GAUTAM, H., KAPIL, A. & BHATNAGAR, S. 2019.

Microbial and antibiotic susceptibility profile among isolates of clinical samples of cancer patients admitted in the intensive care unit at regional tertiary care cancer center: a retrospective observational study. Indian Journal of Critical Care Medicine: Peer-reviewed, Official Publication of Indian Society of Critical Care Medicine, 23, 67.

GIRARDEAU, J. P., DALMASSO, A., BERTIN, Y., DUCROT, C., BORD, S., LIVRELLI, V., etal, 2005. Association of virulence genotype with phylogenetic background in comparison to different seropathotypes of Shiga toxin-producing Escherichia coli isolates. Journal of Clinical Microbiology, 43, 6098-6107.

GONG, Z., SHI, X., BAI, F., HE, X., ZHANG, H., LI, Y., etal, 2019. Characterization of a Novel Diarrheagenic Strain of Proteus mirabilis Associated With Food Poisoning in China. Frontiers in Microbiology, 10.

JAWAD, S. 2020. Molecular Study of Enterobacteriaceae Associated With Colorectal Cancer A Theses Submitted to the Council of the Faculty Education for Girls / The University of Kufa, in Partial Fulfillment of the Requirements for the Degree of Doctorate of Philosophy in Biology. Kufa.

JOFFRE, E., NICKLASSON, M., ÁLVAREZ-CARRETERO, S., XIAO, X., SUN, L., NOOKAEW, I., etal, 2019. The bile salt glycocholate induces global changes in gene and protein expression and activates virulence in enterotoxigenic Escherichia coli. Scientific Reports, 9, 1-14.

KAUR, K., TARASSOVA, O., DANGETI, R. V., AZMI, S., WISHART, D., MCMULLEN, L. 2016. Characterization of a highly potent antimicrobial peptide microcin N from uropathogenic Escherichia coli. FEMS Microbiology Letters, 363, fnw095.

LITTLE, M. S., PELLOCK, S. J., WALTON, W. G., TRIPATHY, A. 2018. Structural basis for the regulation of β-glucuronidase expression by human gut Enterobacteriaceae. Proceedings of the National Academy of Sciences, 115, E152-E161.

LIU, Y., LIU, B., YANG, P., WANG, T., CHANG, Z., WANG, J., WANG, etal, 2019. LysR-type transcriptional regulator OvrB encoded in O island 9 drives enterohemorrhagic Escherichia coli O157: H7 virulence. Virulence, 10, 783-792.

MARKOU, P. 2014. Pathogenesis of intestinal Pseudomonas aeruginosa infection in patients with cancer. Frontiers i Cellular and Infection Microbiology, 3.

MONTASSIER, E., BATARD, E., GASTINNE, T., POTEL, G. 2013. Recent changes in bacteremia in patients with cancer: a systematic review of epidemiology and antibiotic resistance. European Journal of Clinical Microbiology & Infectious Diseases, 32, 841-850.

NIMNOI, P. 2020. Distribution and expression of virulence genes in potentially pathogenic bacteria isolated from seafood in Thailand. CyTA-Journal of Food, 18, 753-763.

NOWROUZIAN, F. L. 2012. Escherichia coli strains with the capacity for long-term persistence in the bowel microbiota carr the potentially genotoxic pks island. Microbial pathogenesis, 53, 180-182.

PARSA, N. 2012. Environmental factors inducing human cancers. Iranian Journal of Public Health, 41, 1.

PATERSON, D. L. 2006. Resistance in gram-negative bacteria: Enterobacteriaceae. American Journal of Infection Control, 34, S20-S28.

POEY, M. E., AZPIROZ, M. F. 2006. Comparative analysis of chromosome-encoded microcins. Antimicrobial Agents and Chemotherapy, 50, 1411-1418.

RAISCH, J., BUC, E., BONNET, M., SAUVANET, P., VAZEILLE, E., DE VALLÉE, A., etal, 2014. Colon cancer-associated B2 Escherichia coli colonize gut mucosa and promote cell proliferation. World Journal of Gastroenterology: WJG, 20, 6560.

RUDDON, R. W. 2007. Cancer biology, University of Michigan Medical School, Oxford University Press. VUOTTO, F., BERTHON, C., LEMAITRE, N., DUHAMEL, A., BALKARAN, S., LE RAY, E., MICOL, J. B., FAURE, K. 2013. Risk factors, clinical features, and outcome of Pseudomonas aeruginosa bacteremia in patients with hematologic malignancies: a case-control study. American Journal of Infection Control, 41, 527-530.

Downloads

Published

2023-04-16

How to Cite

Othman, S. I., & Ali, F. A. (2023). Molecular Comparative Study of Virulence Factors Produced by Gram-Negative Bacteria Isolated from Several Cancer Cases and NonCancer Patients in Erbil Governorate, Iraq. Polytechnic Journal, 12(2), 92-99. https://doi.org/10.25156/ptj.v12n2y2022.pp92-99

Issue

Section

Research Articles

Most read articles by the same author(s)